Physician profile
Kara J Stackley
NPI 1306146295
$383.41
in general payments reported to CMS, 2019-2025
10 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.09 · 2023: $151 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $283 · Entertainment: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $282.56 |
| Entertainment | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $125.09 | 2025 | General - Erectile Dysfunction |
| Abbvie INC. | $91.64 | 2021-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.70 | 2023 | |
| Glaxosmithkline, LLC. | $36.14 | 2023 | Shingrix, Arexvy |
| Exact Sciences Corporation | $20.60 | 2025 | Cologuard Collection Kit |
| Pfizer INC. | $19.68 | 2023 | |
| Amgen INC. | $13.92 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $13.83 | 2023 | Farxiga |
| Optos, INC. | $13.76 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Novo Nordisk INC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kara Stackley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.